Singapore, Singapore · Founded 2020 · Privately Held (backing)
Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. Nuevocor is based in Singapore, Singapore and was founded in 2020. Its last reported valuation was $30.1 million in Nov 2022. It has raised $80.6 million.
Last reported valuation
$30.1M
Oct 2026
Priced at
—
Total raised
$80.6M
Last round
—
Cap table — not yet on record
Nuevocor's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nuevocor with a free account
·The complete investor list: 12 names
·Watch Nuevocor: the Monday email on marks, rounds and moves
